Crossmark

Reply to the Letter to Editor regarding “Autoimmune hepatitis with history of HCV treatment triggered by COVID‑19 vaccination: case report and literature review”

Crossref DOI link: https://doi.org/10.1007/s12328-022-01685-7

Published Online: 2022-08-10

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hasegawa, Naoyuki https://orcid.org/0000-0002-1005-8498
Matsuoka, Ryota

Ishikawa, Naoki

Endo, Masato

Terasaki, Masahiko

Seo, Emiko

Tsuchiya, Kiichiro
License Information

Text and Data Mining valid from 2022-08-10

Version of Record valid from 2022-08-10
More Information

Article History

Received: 11 July 2022

Accepted: 1 August 2022

First Online: 10 August 2022

Declarations

:

: The authors declare that they have no conflicts of interest.

: The authors declare that this study conformed to the Declaration of Helsinki.

: Informed consent was obtained from the patient for being included in this study.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below